询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
Cucurbitacin I | CAS:2222-07-3
Cucurbitacin I
  • 名称:葫芦素 | Cucurbitacin I
  • CAS号:2222-07-3
  • 别名:2,16a,20,25-Tetrahydroxy-9b-methyl-10a-19-norlanosta-1,5,23(E)-triene-3,11,22-trione
  • 分子式:C30H42O7
  • 分子量:514.65
  • EINESC号:218-736-8

产品描述

物理化学性质

没有数据没有数据

安全数据

危险品标志 T+
危险类别码 R28
安全说明书 S28;S36/37;S45

SDS

来源 SDS样本
Sigma-Aldrich 浏览或下载
Carl-Roth 浏览或下载
Cayman 浏览或下载
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
Vulvovaginal candidosis: comparison of 3-day treatment with 2% butoconazole nitrate cream and 6-day treatment with 1% clotrimazole cream.A J Hajman The Journal of international medical research, 16(5), 367-375 (1988-09-01) Direct lethal action of sulconazole and butoconazole.W H Beggs Annales de dermatologie et de venereologie, 118 Suppl 1, 5-6 (1991-01-01) Development of a liquid chromatography-tandem mass spectrometry method for determination of butoconazole nitrate in human plasma and its application to a pharmacokinetic study.Meng-meng Jia et al.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 34(3), 431-436 (2014-06-19) Patient acceptance of prefilled disposable vaginal applicator.M E LePage et al.American journal of obstetrics and gynecology, 158(4), 1006-1008 (1988-04-01) [Butoconazole nitrate in vulvovaginal candidiasis. A comparative study with clotrimazole].E Herrera Nava et al.Ginecologia y obstetricia de Mexico, 56, 138-143 (1988-05-01) [The statement of Polish Gynecological Society Experts on the treatment of acute vulvovaginal candidiasis with prolonged releasing 2% butoconazole nitrate vaginal cream--state of art in 2008]. Ginekologia polska, 80(4), 303-311 (2009-06-11) Drugs for vulvovaginal candidiasis. The Medical letter on drugs and therapeutics, 43(1095), 3-4 (2001-01-11) Severe reversible thrombocytopenia resulting from butoconazole cream.P A Maloley et al.DICP : the annals of pharmacotherapy, 24(2), 143-144 (1990-02-01) Control of Candida albicans vaginitis in mice by short-duration butoconazole treatment in situ.A Valentin et al.Mycoses, 36(11-12), 379-384 (1993-11-01) In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.J M Hernández Molina et al.Mycopathologia, 118(1), 15-21 (1992-04-01) [In vitro evaluation of the activity of butoconazole against Trichomonas vaginalis].P Bourée et al.Pathologie-biologie, 40(5), 492-494 (1992-05-01) [Action of 2 new imidazole derivatives (butoconazole and sulconazole) on Candida, Trichophyton and Aspergillus].J P Latge et al.Annales de dermatologie et de venereologie, 116 Suppl 1, 20-23 (1989-01-01) Switches to OTC require more of patients.S L Chase RN, 59(6), 70-70 (1996-06-01) In vitro evaluation of artificial ageing on surface properties and early Candida albicans adhesion to prosthetic resins.Sebastian Hahnel et al.Journal of materials science. Materials in medicine, 20(1), 249-255 (2008-09-02) [Treatment in cases of recurrent vaginal candida infection during pregnancy].A Nikolov et al.Akusherstvo i ginekologiia, 46(9), 23-26 (2008-07-23) Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans.M A Pfaller et al.Diagnostic microbiology and infectious disease, 13(1), 31-35 (1990-01-01) A new vaginal antifungal agent--butoconazole nitrate.J B Jacobson et al.Acta obstetricia et gynecologica Scandinavica, 64(3), 241-244 (1985-01-01) A comparison of butoconazole nitrate cream with econazole nitrate cream for the treatment of vulvovaginal candidiasis.H Ruf et al.The Journal of international medical research, 18(5), 389-399 (1990-09-01) Effect of butoconazole nitrate cream and wax insert on the barrier property of contraceptive devices.A B Wong American journal of obstetrics and gynecology, 158(4), 1011-1013 (1988-04-01) Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group.D Brown et al.The Journal of reproductive medicine, 44(11), 933-938 (1999-12-10) Vaginal retention of 2% butoconazole nitrate cream: comparison of a standard and a sustained-release preparation.L Weinstein et al.Clinical therapeutics, 16(6), 930-934 (1994-11-01) An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.Larry S Seidman et al.Infectious diseases in obstetrics and gynecology, 13(4), 197-206 (2005-12-13) Drugs for treatment of vulvovaginal candidiasis: comparative efficacy of agents and regimens.P L Doering et al.DICP : the annals of pharmacotherapy, 24(11), 1078-1083 (1990-11-01) Efficacy of butoconazole nitrate in the treatment of vulvo-vaginal candidiasis compared with clotrimazol and isoconasol.A López Fiesco et al.Proceedings of the Western Pharmacology Society, 36, 185-188 (1993-01-01) Treatment of recurrent vulvo-vaginal candidiasis with sustained-released butoconazole pessary.Ling Zhi Heng et al.Singapore medical journal, 53(12), e269-e271 (2012-12-27) [Gynazol for treatment of vulvo-vaginal candidiasis--our experience].E Rachev Akusherstvo i ginekologiia, 46(2), 25-27 (2007-05-02) Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis.R H Kaufman et al.The Journal of reproductive medicine, 34(7), 479-483 (1989-07-01)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交